Riskpilot← Back to searchSign inGet full accessHÁ BIOTECH AS
ASActiveOrg 924461594Botnaneset 24, 6900 FlorøResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20201 employees
Revenue 2024
NOK 0
EBITDA margin
—
-36% vs 2023
Equity ratio
86.3%
Financial strength
Net profit 2024
NOK -1,3M
-40% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -1,3M | -36% |
| Net profit | NOK -1,3M | -40% |
| Total assets | NOK 9M | +3999% |
| Equity | NOK 7,7M | +17943% |
| Employees | 1 | — |
Legal name
HÁ BIOTECH AS
Org number
924461594
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
22. januar 2020
Share capital
NOK 1 650 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Forskning, utvikling og produksjon innen bioteknologi, samt annen virksomhet som naturlig står i forbindelse med dette.
Address
Botnaneset 24, 6900 Florø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −397 | −1 000 |
| EBITDA | 0 | −70 | −82 | −47 | −988 | −1 340 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −70 | −82 | −47 | −988 | −1 340 |
| Net financials | 0 | 0 | 0 | 13 | 31 | 3 |
| Profit before tax | 0 | −70 | −82 | −34 | −957 | −1 337 |
| Tax | 0 | −15 | −18 | −7 | −0 | −0 |
| Net profit | 0 | −54 | −64 | −27 | −957 | −1 337 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 1 000 | 1 006 | 1 000 | 1 000 | 219 | 8 972 |
| Equity | 1 000 | 1 000 | 1 000 | 1 000 | 43 | 7 740 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 6 | 0 | 0 | 176 | 1 231 |
| Total debt | 0 | 6 | 0 | 0 | 176 | 1 231 |
EBITDA margin
-134011000.0%
This company
15.8%
Market median
-848170986% vs market
20192024
Equity ratio
86.3%
This company
38.2%
Market median
+126% vs market
20192024
Return on equity
-17.3%
This company
18.4%
Market median
-194% vs market
20192024
Net profit margin
-133715600.0%
This company
8.1%
Market median
-1650809977% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OK Deputy Member | Deputy Member | 2024 | — | — |
TV Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
ØE Deputy Member | Deputy Member | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Havlandet Havbruk As | Company | 100.0% | 100.0% | 2022 |
Sarsia Fond Iii As | Company | 20.0% | 20.0% | 2024 |
Ranel As | Company | 20.0% | 20.0% | 2024 |
Havlandet Breed As | Company | 20.0% | 20.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sarsia Fond Iii As
HÁ BIOTECH AS Board members of HÁ BIOTECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Oda Kristin Igland | Deputy Member | 0 companies |
| Torgeir Vaage | Chief Executive Officer | 0 companies |
| Øivind Enger | Deputy Member | 0 companies |
| Oddgeir Ragnar Igland | Chairman | 0 companies |
| Henrik Solberg-Johansen | Board of Directors | 0 companies |
| Bjørn Tore Gjertsen | Board of Directors | 0 companies |
| Bjørn Inge Igland | Chairman | 0 companies |
| Halvard Andalsvik Hovland | Board of Directors | 0 companies |
| Tor Christian Bringedal | Board of Directors | 0 companies |